These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3043434)

  • 61. Benz[a]anthracene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():135-45. PubMed ID: 6586643
    [No Abstract]   [Full Text] [Related]  

  • 62. Anthanthrene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():95-104. PubMed ID: 6586680
    [No Abstract]   [Full Text] [Related]  

  • 63. Anthracene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():105-21. PubMed ID: 6586640
    [No Abstract]   [Full Text] [Related]  

  • 64. Fluoranthene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():355-64. PubMed ID: 6586670
    [No Abstract]   [Full Text] [Related]  

  • 65. Iron and steel founding.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1984 Jun; 34():133-90. PubMed ID: 6595208
    [No Abstract]   [Full Text] [Related]  

  • 66. Malonaldehyde.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1985 Feb; 36():163-77. PubMed ID: 3864731
    [No Abstract]   [Full Text] [Related]  

  • 67. Dibenz[a,c]anthracene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():289-97. PubMed ID: 6586660
    [No Abstract]   [Full Text] [Related]  

  • 68. Pyrene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():431-45. PubMed ID: 6586678
    [No Abstract]   [Full Text] [Related]  

  • 69. 1-, 2-, 3-, 4-, 5- and 6-Methylchrysenes.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():379-97. PubMed ID: 6586673
    [No Abstract]   [Full Text] [Related]  

  • 70. On the stereochemistry of fecapentaene-12.
    Kingston DG; Piccariello T; Duh CY; Govindan SV; Wilkins TD; van Tassell RL; Van der Gen A; De Wit PP; Van der Steeg M
    J Nat Prod; 1988; 51(1):176-9. PubMed ID: 3373225
    [No Abstract]   [Full Text] [Related]  

  • 71. The precursors of fecapentaenes: purification and properties of a novel plasmalogen.
    Van Tassell RL; Piccariello T; Kingston DG; Wilkins TD
    Lipids; 1989 May; 24(5):454-9. PubMed ID: 2755322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chloroprene and polychloroprene.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Feb; 19():131-56. PubMed ID: 285917
    [No Abstract]   [Full Text] [Related]  

  • 73. Structures of fecapentaenes, the mutagens of bacterial origin isolated from human feces.
    Gupta I; Baptista J; Bruce WR; Che CT; Furrer R; Gingerich JS; Grey AA; Marai L; Yates P; Krepinsky JJ
    Biochemistry; 1983 Jan; 22(2):241-5. PubMed ID: 6824628
    [No Abstract]   [Full Text] [Related]  

  • 74. Laboratory and epidemiologic studies of fecapentaenes.
    Povey AC; Schiffman M; Taffe BG; Harris CC
    Mutat Res; 1991; 259(3-4):387-97. PubMed ID: 2017218
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The precursors of fecapentaenes. A preliminary report.
    Van Tassell RL; Wilkins TD
    Ann Ist Super Sanita; 1986; 22(3):933-41. PubMed ID: 3826998
    [No Abstract]   [Full Text] [Related]  

  • 76. Formation and biological effects of fecapentaenes.
    Krepinsky JJ
    Prog Biochem Pharmacol; 1988; 22():35-47. PubMed ID: 3043434
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.